<DOC>
	<DOCNO>NCT01902121</DOCNO>
	<brief_summary>A Phase 1 , open-label , randomize , crossover study 36 healthy normal volunteer ( HNVs ) evaluate bioequivalence TI Inhalation Powder deliver use Gen2 Inhaler administer one 30 U cartridge versus combination one 10 U cartridge one 20 U cartridge .</brief_summary>
	<brief_title>Compare Same Dosage Insulin Using Combination Cartridges , 30 Units 2 Cartridges vs. 1 Cartridge</brief_title>
	<detailed_description />
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Men woman age 18 45 year , consider healthy base screen physical examination , medical history , clinical chemistry , urinalysis No smoking past 6 month ( include cigarette , cigar , pipe ) Urine cotinine test &lt; 100 ng/mL Body mass index &lt; 32 kg/m2 Completion inform consent form FBG &gt; 100 mg/dL Clinically significant active chronic illness History asthma , chronic obstructive pulmonary disease ( COPD ) , clinically relevant chronic lung disease Respiratory tract infection within 4 week screen screen visit dose visit Subjects experience persistent recur cough , wheeze , bronchospasm , dyspnea</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>